Reported Dec 19, 2018 · Terminated

Westminster Irbesartan Tablets, USP 300 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788…

Westminster Pharmaceuticals LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Westminster Pharmaceuticals Llc · 1 & 2 · Olive Branch, MS · 38654

Is this the product you have?

  • Westminster Irbesartan Tablets
  • USP 300 mg Rx Only Manufactured byScieGen Pharmaceuticals, Inc. Hauppauge
  • NY 11788 Manufactured forWestminster Pharmaceuticals, LLC. Olive Branch, MS 38654 a) 30 count bottle NDC 69367-121-01; b) 90 count bottle NDC 69367-121-03
Lot codes and dates
  • Batch Numbers
    • a) B162008A Exp. 09/30/2019
    • C162002A Exp. 02/29/2020
    • b) B162008B Exp. 09/30/2019
    • C162002B Exp. 02/29/2020
Amount recalled
3976 bottles

This recall covers 3 products

The agency filed one notice per product. You are reading one of them; the other 2 are below.

Where it was sold

  • Nationwide

Why it was recalled

CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in specific lots of Irbesartan.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Westminster Pharmaceuticals LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Oct 26, 2021 · Data as of Sep 19, 6:36 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.